Research Recap

NASH in Diabetes: New Therapies on the Horizon With 'a host' of treatments in the pipeline, fatty liver disease no longer plays second fiddle to diabetes-related cardiovascular disease and chronic kidney disease, says researcher Gregory Nichols.
Experts And Viewpoints, October 23, 2019
New Weapons Against Cardiorenal Syndrome Cardiovascular outcomes trials show beneficial effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on both cardiovascular and renal outcomes, sparking renewed interest in cardiorenal syndrome.
Experts And Viewpoints, June 24, 2019
Amputations in Diabetes Back on the Rise, but Why? After a steady decline in rates of amputation in patients with diabetes, a new study shows that rates are increasing, with few obvious explanations as to why.
Experts And Viewpoints, March 14, 2019
SGLT2 Inhibitors: Is This the Start of a New Era? Gregory Nichols discusses exciting new clinical trial results demonstrating the benefits of SGLT2 inhibitors, as presented at the AHA 2018 Scientific Sessions.
December 07, 2018
Prevention of Type 2 Diabetes Highlighted at EASD 2018 Dietary changes and regular exercise are proven interventions that reduce the risk for type 2 diabetes, but with rates of obesity on the rise, other strategies may be required.
November 01, 2018
A Quick Planner for ADA ADA meeting veteran Gregory Nichols offers a guide to the upcoming ADA 78th Scientific Sessions and which sessions have sparked his interest.
June 14, 2018
Simple Tool Predicts 2-Year Diabetes Risk An operational question about allocating diabetes resources results in a simple algorithm that identifies the people at highest risk for developing diabetes.
Experts And Viewpoints, June 06, 2018
Anatomy of a Research Project: From Idea to Publication Ever wonder how a medical study got its start? A researcher shares his personal journey.
Experts And Viewpoints, March 19, 2018
What Comes After Metformin in Type 2 Diabetes? Choosing the right drug for the right patient can affect glycemic control and mortality outcomes.
Experts And Viewpoints, January 26, 2018
In T2D, How Low Should BP Go? Should most patients with diabetes be on intensive blood pressure interventions?
Experts And Viewpoints, October 20, 2017
Reducing CV Risk in Diabetes: 'When' and 'How' Matter Reducing cardiovascular risk with glycemic control may depend on when and how it is achieved.
Experts And Viewpoints, July 19, 2017
Entering Adulthood With Diabetes Whether it's type 1 or 2, diabetes in youth requires early and aggressive management. Dr Nichols reviews new research on disease course and challenges associated with transition to adult care.
Experts And Viewpoints, July 13, 2017
Assess Patients With Diabetes for Sleep Quality Poor sleep may have profound effects on people with diabetes, as well as risk for diabetes.
Experts And Viewpoints, April 17, 2017
Paradigm Change in Diabetes Care: Prompt, Intensive Therapy Gregory Nichols links the findings of two important diabetes trials to suggest that earlier and more effective therapy could save lives and prevent complications.
Experts And Viewpoints, October 04, 2016
Fitness, Fatness, and Risk for Diabetes What role do body weight and fitness level play in the risk for prediabetes and diabetes? And is it too late to reverse these trends?
Experts And Viewpoints, August 17, 2016
Is A1c Variability a Useful Measure in Diabetes? Fluctuations in glycated hemoglobin levels have been suggested as an independent risk factor for diabetic complications, but new studies cast doubts on that concept.
Experts And Viewpoints, March 21, 2016
Personalizing Diabetes Treatment Targets When patients respond to treatment, how often do providers deintensify their treatment? A new algorithm may simplify and personalize that decision.
Experts And Viewpoints, December 29, 2015
After Metformin, What Comes Next? Empagliflozin? Are we any closer to answering the question of what drug should be added when metformin monotherapy needs a boost? Two studies shed some light.
Experts And Viewpoints, December 22, 2015
Type 2 Diabetes Can Be Prevented: Why Are We Waiting? Despite the evidence supporting benefit, clinicians have been slow to recommend either healthy lifestyle changes or metformin for diabetes prevention.
Experts And Viewpoints, August 17, 2015
Skip the Weigh-in for Type 2 Diabetes Patients? Does fitness explain the 'obesity paradox'? Dr Nichols examines two new studies that may add to our understanding of this phenomenon.
Experts And Viewpoints, June 29, 2015

No Results